{"id":129433,"title":"hMPV Interview with Guy Boivin & hVIVO’s Chief Scientific Officer","publisher":"Share Talk","author":"sharetalk","published":"2025-11-19T10:34:59+00:00","modified":"2025-11-19T10:34:59+00:00","canonical_url":"https://www.share-talk.com/hmpv-interview-with-guy-boivin-hvivos-chief-scientific-officer/","markdown_url":"https://www.share-talk.com/hmpv-interview-with-guy-boivin-hvivos-chief-scientific-officer.md","json_url":"https://www.share-talk.com/hmpv-interview-with-guy-boivin-hvivos-chief-scientific-officer.json","category":"Exclusive Interviews","categories":["Exclusive Interviews","Health","Healthcare","Pharmaceutical"],"tags":["Andrew Catchpole","antiviral","breast cancer","Canary Wharf","Cathal Friel","CHIMagents","clinical respiratory drug","Codagenix","COVID-19","Dengue Fever","Dr Andrew Catchpole","Dr Chris Chiu","Gregory Stoloff","hVIVO","Imperial College London","Imutex Ltd","laboratory","Malaria","Open Orphan","ORPH","Oxford BioTherapeutics","pharmaceutical","quarantine clinic","Rahim Fandi","Share Talk","Stephen Pinkerton","The Lancet","Vaccine","virology","West Nile Virus","Yamin 'Mo' Khan","Zika"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2025/11/2-hMPV-Interview-with-Guy-Boivin-hVIVOs-Chief-Scientific-Officer-You.-2025-11-19-at-10.16.00-AM.webp?fit=1200%2C597&quality=80&ssl=1","format":"news","language":"en-GB","content":"Join us for an insightful conversation on [hMPV](https://www.share-talk.com/hvivo-plc-diversification-in-action-as-2026-growth-beckons/) featuring our Chief Scientific Officer, Dr Andrew Catchpole and Guy Boivin, a professor from Laval University and one of the founding fathers in the discovery and ongoing research into hMPV.\n\nhMPV’s discovery\n\n‍ Need to find a treatment to address hMPV\n\nThe burden and severities of hMPV\n\nCould hMPV be the next pandemic?\n\n[hVIVO](https://www.share-talk.com/hvivo-plc-diversification-in-action-as-2026-growth-beckons/) is proud to play a small part in the hMPV story by developing the first commercially available hMPV human challenge study.\n\nIf you would like to learn more about hMPV, reach out to us directly via [bd@hvivo.com](mailto:bd@hvivo.com)"}